Tapewire

Nasdaq · USD

SNPS

SYNOPSYS INC

Export transactions ↓
Tapewire entity
210
SEC CIK
0000883241
Parsed reports
579

Last 12 months

Inside the activity.

0 purchase rows · 14 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202502
Jan 202602
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202602
Jul 202600
Aug 202602
Sep 202602
Oct 202604

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 27, 2024 Filed Jun 28, 2024 16:08 UTC
DE GEUS AARTDirector · EXECUTIVE CHAIR
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 8,158 $0.00 Strike: $89.76 $0.00
Disclosure

SEC source: 0001517737-24-000079 · edgardoc.xml · derivative · entry 9

DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 86,842

Underlying: Common Stock · 8,158 shares

Expires 2025-12-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted March 25, 2024.

Read SEC document
June 27, 2024 Filed Jun 28, 2024 16:08 UTC
DE GEUS AARTDirector · EXECUTIVE CHAIR
SaleCommon Stock 8,158 $602.59 $4,915,912.90
Disclosure

SEC source: 0001517737-24-000079 · edgardoc.xml · nonDerivative · entry 4

DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 106,983

F2 · price: Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $600.31 to $605.78. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.

Read SEC document
June 27, 2024 Filed Jun 28, 2024 16:08 UTC
DE GEUS AARTDirector · EXECUTIVE CHAIR
Exercise / conversionCommon Stock 8,158 $89.76 $732,262.08
Disclosure

SEC source: 0001517737-24-000079 · edgardoc.xml · nonDerivative · entry 3

DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 115,141

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 26, 2024 Filed Jun 28, 2024 16:08 UTC
DE GEUS AARTDirector · EXECUTIVE CHAIR
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 2,899 $0.00 Strike: $89.76 $0.00
Disclosure

SEC source: 0001517737-24-000079 · edgardoc.xml · derivative · entry 8

DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 95,000

Underlying: Common Stock · 2,899 shares

Expires 2025-12-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted March 25, 2024.

Read SEC document
June 26, 2024 Filed Jun 28, 2024 16:08 UTC
DE GEUS AARTDirector · EXECUTIVE CHAIR
SaleCommon Stock 2,899 $600.57 $1,741,062.00
Disclosure

SEC source: 0001517737-24-000079 · edgardoc.xml · nonDerivative · entry 2

DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 106,983

F1 · price: Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $600.000 to $601.265. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.

Read SEC document
June 26, 2024 Filed Jun 28, 2024 16:08 UTC
DE GEUS AARTDirector · EXECUTIVE CHAIR
Exercise / conversionCommon Stock 2,899 $89.76 $260,214.24
Disclosure

SEC source: 0001517737-24-000079 · edgardoc.xml · nonDerivative · entry 1

DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 109,882

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 25, 2024 Filed Jun 26, 2024 14:40 UTC
DE GEUS AARTDirector · EXECUTIVE CHAIR
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 4,212 $0.00 Strike: $89.76 $0.00
Disclosure

SEC source: 0001517737-24-000077 · edgardoc.xml · derivative · entry 9

DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 97,899

Underlying: Common Stock · 4,212 shares

Expires 2025-12-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted March 25, 2024.

Read SEC document
June 25, 2024 Filed Jun 26, 2024 14:40 UTC
DE GEUS AARTDirector · EXECUTIVE CHAIR
SaleCommon Stock 4,212 $600.05 $2,527,413.97
Disclosure

SEC source: 0001517737-24-000077 · edgardoc.xml · nonDerivative · entry 4

DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 106,983

F2 · price: Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $600.00 to $600.28 The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.

Read SEC document
June 25, 2024 Filed Jun 26, 2024 14:40 UTC
DE GEUS AARTDirector · EXECUTIVE CHAIR
Exercise / conversionCommon Stock 4,212 $89.76 $378,069.12
Disclosure

SEC source: 0001517737-24-000077 · edgardoc.xml · nonDerivative · entry 3

DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 111,195

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 24, 2024 Filed Jun 26, 2024 14:40 UTC
DE GEUS AARTDirector · EXECUTIVE CHAIR
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 2,535 $0.00 Strike: $89.76 $0.00
Disclosure

SEC source: 0001517737-24-000077 · edgardoc.xml · derivative · entry 8

DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 102,111

Underlying: Common Stock · 2,535 shares

Expires 2025-12-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted March 25, 2024.

Read SEC document
June 24, 2024 Filed Jun 26, 2024 14:40 UTC
DE GEUS AARTDirector · EXECUTIVE CHAIR
SaleCommon Stock 2,535 $600.99 $1,523,497.99
Disclosure

SEC source: 0001517737-24-000077 · edgardoc.xml · nonDerivative · entry 2

DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 106,983

F1 · price: Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $600.000 to $602.655. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.

Read SEC document
June 24, 2024 Filed Jun 26, 2024 14:40 UTC
DE GEUS AARTDirector · EXECUTIVE CHAIR
Exercise / conversionCommon Stock 2,535 $89.76 $227,541.60
Disclosure

SEC source: 0001517737-24-000077 · edgardoc.xml · nonDerivative · entry 1

DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 109,518

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 18, 2024 Filed Jun 21, 2024 15:25 UTC
MAHONEY RICHARD S.Chief Revenue Officer
SaleCommon Stock 3,316 $611.41 $2,027,435.56
Disclosure

SEC source: 0001517737-24-000075 · edgardoc.xml · nonDerivative · entry 1

MAHONEY RICHARD S. · CIK 0001693085 · Chief Revenue Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,265

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted September 13, 2023.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 15:10 UTC
MAHONEY RICHARD S.Chief Revenue Officer
Disposition to issuerRestricted Stock Units · Derivative 7,832 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001517737-24-000073 · edgardoc.xml · derivative · entry 3

MAHONEY RICHARD S. · CIK 0001693085 · Chief Revenue Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,664

Underlying: Common Stock · 7,832 shares

Expires 2026-06-15

F2 · derivative.exercise_date: 25% of the units vest on the date shown followed by three equal annual installments, subject to continued service through each vesting date.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 15:10 UTC
MAHONEY RICHARD S.Chief Revenue Officer
Tax withholdingCommon Stock 3,411 $590.21 $2,013,206.31
Disclosure

SEC source: 0001517737-24-000073 · edgardoc.xml · nonDerivative · entry 2

MAHONEY RICHARD S. · CIK 0001693085 · Chief Revenue Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,581

F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the reporting person in connection with the vesting of an installment of the restricted stock unit award. The Compensation Committee approved the disposition of shares by the reporting person and the amount retained by the Company was not in excess of the amount of the tax liability.

Read SEC document
June 15, 2024 Filed Jun 18, 2024 15:10 UTC
MAHONEY RICHARD S.Chief Revenue Officer
Exercise / conversionCommon Stock 7,832 $0.00 $0.00
Disclosure

SEC source: 0001517737-24-000073 · edgardoc.xml · nonDerivative · entry 1

MAHONEY RICHARD S. · CIK 0001693085 · Chief Revenue Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,992

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 10, 2024 Filed Jun 12, 2024 14:54 UTC
RUNKEL JOHN F JRGC & Corporate Secretary
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 366 $0.00 Strike: $354.48 $0.00
Disclosure

SEC source: 0001517737-24-000071 · edgardoc.xml · derivative · entry 6

RUNKEL JOHN F JR · CIK 0001206990 · GC & Corporate Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,197

Underlying: Common Stock · 366 shares

Expires 2028-12-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted September 29, 2023.

F2 · derivative.exercise_date: 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.

Read SEC document
June 10, 2024 Filed Jun 12, 2024 14:54 UTC
RUNKEL JOHN F JRGC & Corporate Secretary
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 570 $0.00 Strike: $234.17 $0.00
Disclosure

SEC source: 0001517737-24-000071 · edgardoc.xml · derivative · entry 5

RUNKEL JOHN F JR · CIK 0001206990 · GC & Corporate Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,139

Underlying: Common Stock · 570 shares

Expires 2027-12-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted September 29, 2023.

F2 · derivative.exercise_date: 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.

Read SEC document
June 10, 2024 Filed Jun 12, 2024 14:54 UTC
RUNKEL JOHN F JRGC & Corporate Secretary
SaleCommon Stock 570 $566.97 $323,172.90
Disclosure

SEC source: 0001517737-24-000071 · edgardoc.xml · nonDerivative · entry 4

RUNKEL JOHN F JR · CIK 0001206990 · GC & Corporate Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,000

Read SEC document
June 10, 2024 Filed Jun 12, 2024 14:54 UTC
RUNKEL JOHN F JRGC & Corporate Secretary
Exercise / conversionCommon Stock 570 $234.17 $133,476.90
Disclosure

SEC source: 0001517737-24-000071 · edgardoc.xml · nonDerivative · entry 3

RUNKEL JOHN F JR · CIK 0001206990 · GC & Corporate Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,570

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 10, 2024 Filed Jun 12, 2024 14:54 UTC
RUNKEL JOHN F JRGC & Corporate Secretary
SaleCommon Stock 366 $566.97 $207,511.02
Disclosure

SEC source: 0001517737-24-000071 · edgardoc.xml · nonDerivative · entry 2

RUNKEL JOHN F JR · CIK 0001206990 · GC & Corporate Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,000

Read SEC document
June 10, 2024 Filed Jun 12, 2024 14:54 UTC
RUNKEL JOHN F JRGC & Corporate Secretary
Exercise / conversionCommon Stock 366 $354.48 $129,739.68
Disclosure

SEC source: 0001517737-24-000071 · edgardoc.xml · nonDerivative · entry 1

RUNKEL JOHN F JR · CIK 0001206990 · GC & Corporate Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,366

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 28, 2024 Filed May 29, 2024 16:18 UTC SaleCommon Stock 5,500 $581.38 $3,197,590.00
Disclosure

SEC source: 0001517737-24-000069 · edgardoc.xml · nonDerivative · entry 1

JOHNSON MERCEDES · CIK 0001225110 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · by Trust

Disclosed balance after: 1,543

F1 · balance_after: Prior to May 28, 2024, the reporting person held 2,053 shares under direct ownership and 5,346 shares under indirect ownership. Of the 2,053 shares held under direct ownership the reporting person transferred 1,697 shares into the Mercedes Johnson Trust. The Transfer is exempt from Section 16 by virtue of Rule 16a-13. The shares are indirectly held by the reporting person through the Mercedes Johnson Trust.

Read SEC document
May 24, 2024 Filed May 29, 2024 16:18 UTC
Ghazi SassineDirector · PRESIDENT AND CEO
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 10,294 $0.00 Strike: $90.51 $0.00
Disclosure

SEC source: 0001517737-24-000068 · edgardoc.xml · derivative · entry 3

Ghazi Sassine · CIK 0001822289 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,293

Underlying: Common Stock · 10,294 shares

Expires 2024-12-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted September 27, 2023.

Read SEC document
May 24, 2024 Filed May 29, 2024 16:18 UTC
Ghazi SassineDirector · PRESIDENT AND CEO
SaleCommon Stock 10,294 $582.41 $5,995,300.75
Disclosure

SEC source: 0001517737-24-000068 · edgardoc.xml · nonDerivative · entry 2

Ghazi Sassine · CIK 0001822289 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 62,568

F1 · price: Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $580.06 to $584.34. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.

Read SEC document
May 24, 2024 Filed May 29, 2024 16:18 UTC
Ghazi SassineDirector · PRESIDENT AND CEO
Exercise / conversionCommon Stock 10,294 $90.51 $931,709.94
Disclosure

SEC source: 0001517737-24-000068 · edgardoc.xml · nonDerivative · entry 1

Ghazi Sassine · CIK 0001822289 · Director · PRESIDENT AND CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 72,862

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 24, 2024 Filed May 29, 2024 16:17 UTC
RUNKEL JOHN F JRGC & Corporate Secretary
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 366 $0.00 Strike: $354.48 $0.00
Disclosure

SEC source: 0001517737-24-000067 · edgardoc.xml · derivative · entry 9

RUNKEL JOHN F JR · CIK 0001206990 · GC & Corporate Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,563

Underlying: Common Stock · 366 shares

Expires 2028-12-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted September 29, 2023.

F2 · derivative.exercise_date: 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.

Read SEC document
May 24, 2024 Filed May 29, 2024 16:17 UTC
RUNKEL JOHN F JRGC & Corporate Secretary
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 304 $0.00 Strike: $354.45 $0.00
Disclosure

SEC source: 0001517737-24-000067 · edgardoc.xml · derivative · entry 8

RUNKEL JOHN F JR · CIK 0001206990 · GC & Corporate Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,352

Underlying: Common Stock · 304 shares

Expires 2030-02-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted September 29, 2023.

F2 · derivative.exercise_date: 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.

Read SEC document
May 24, 2024 Filed May 29, 2024 16:17 UTC
RUNKEL JOHN F JRGC & Corporate Secretary
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 569 $0.00 Strike: $234.17 $0.00
Disclosure

SEC source: 0001517737-24-000067 · edgardoc.xml · derivative · entry 7

RUNKEL JOHN F JR · CIK 0001206990 · GC & Corporate Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,709

Underlying: Common Stock · 569 shares

Expires 2027-12-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted September 29, 2023.

F2 · derivative.exercise_date: 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.

Read SEC document
May 24, 2024 Filed May 29, 2024 16:17 UTC
RUNKEL JOHN F JRGC & Corporate Secretary
SaleCommon Stock 569 $582.90 $331,670.10
Disclosure

SEC source: 0001517737-24-000067 · edgardoc.xml · nonDerivative · entry 6

RUNKEL JOHN F JR · CIK 0001206990 · GC & Corporate Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,000

Read SEC document
May 24, 2024 Filed May 29, 2024 16:17 UTC
RUNKEL JOHN F JRGC & Corporate Secretary
Exercise / conversionCommon Stock 569 $234.17 $133,242.73
Disclosure

SEC source: 0001517737-24-000067 · edgardoc.xml · nonDerivative · entry 5

RUNKEL JOHN F JR · CIK 0001206990 · GC & Corporate Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,569

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 24, 2024 Filed May 29, 2024 16:17 UTC
RUNKEL JOHN F JRGC & Corporate Secretary
SaleCommon Stock 366 $582.90 $213,341.40
Disclosure

SEC source: 0001517737-24-000067 · edgardoc.xml · nonDerivative · entry 4

RUNKEL JOHN F JR · CIK 0001206990 · GC & Corporate Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,000

Read SEC document
May 24, 2024 Filed May 29, 2024 16:17 UTC
RUNKEL JOHN F JRGC & Corporate Secretary
Exercise / conversionCommon Stock 366 $354.48 $129,739.68
Disclosure

SEC source: 0001517737-24-000067 · edgardoc.xml · nonDerivative · entry 3

RUNKEL JOHN F JR · CIK 0001206990 · GC & Corporate Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,366

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 24, 2024 Filed May 29, 2024 16:17 UTC
RUNKEL JOHN F JRGC & Corporate Secretary
SaleCommon Stock 304 $582.90 $177,201.60
Disclosure

SEC source: 0001517737-24-000067 · edgardoc.xml · nonDerivative · entry 2

RUNKEL JOHN F JR · CIK 0001206990 · GC & Corporate Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,000

Read SEC document
May 24, 2024 Filed May 29, 2024 16:17 UTC
RUNKEL JOHN F JRGC & Corporate Secretary
Exercise / conversionCommon Stock 304 $354.45 $107,752.80
Disclosure

SEC source: 0001517737-24-000067 · edgardoc.xml · nonDerivative · entry 1

RUNKEL JOHN F JR · CIK 0001206990 · GC & Corporate Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,304

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 10, 2024 Filed Apr 12, 2024 18:29 UTC
Borgen LuisDirector
GrantCommon Stock 356 $0.00 $0.00
Disclosure

SEC source: 0001517737-24-000063 · edgardoc.xml · nonDerivative · entry 1

Borgen Luis · CIK 0001488660 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,342

F1 · date: The shares subject to the Award will vest on the date immediately preceding the first Annual Meeting following the Date of Grant, subject to the Eligible Director's continued Board service through such date.

F2 · kind: Automatic award under the Synopsys 2017 Non-Employee Directors Equity Incentive Plan.

Read SEC document
April 10, 2024 Filed Apr 12, 2024 16:53 UTC
VALLEE ROYDirector
GrantCommon Stock 356 $0.00 $0.00
Disclosure

SEC source: 0001517737-24-000060 · edgardoc.xml · nonDerivative · entry 1

VALLEE ROY · CIK 0001220020 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,622

F1 · date: The shares subject to the Award will vest on the date immediately preceding the first Annual Meeting following the Date of Grant, subject to the Eligible Director's continued Board service through such date.

F2 · kind: Automatic award under the Synopsys 2017 Non-Employee Directors Equity Incentive Plan.

Read SEC document
April 10, 2024 Filed Apr 12, 2024 16:51 UTC
SCHWARZ JOHNDirector
GrantCommon Stock 356 $0.00 $0.00
Disclosure

SEC source: 0001517737-24-000059 · edgardoc.xml · nonDerivative · entry 1

SCHWARZ JOHN · CIK 0001184223 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,296

F1 · date: The shares subject to the Award will vest on the date immediately preceding the first Annual Meeting following the Date of Grant, subject to the Eligible Director's continued Board service through such date.

F2 · kind: Automatic award under the Synopsys 2017 Non-Employee Directors Equity Incentive Plan.

Read SEC document
April 10, 2024 Filed Apr 12, 2024 16:50 UTC GrantCommon Stock 356 $0.00 $0.00
Disclosure

SEC source: 0001517737-24-000058 · edgardoc.xml · nonDerivative · entry 1

Sargent Jeannine P · CIK 0001331845 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,053

F1 · date: The shares subject to the Award will vest on the date immediately preceding the first Annual Meeting following the Date of Grant, subject to the Eligible Director's continued Board service through such date.

F2 · kind: Automatic award under the Synopsys 2017 Non-Employee Directors Equity Incentive Plan.

Read SEC document
April 10, 2024 Filed Apr 12, 2024 16:49 UTC GrantCommon Stock 356 $0.00 $0.00
Disclosure

SEC source: 0001517737-24-000057 · edgardoc.xml · nonDerivative · entry 1

PAINTER ROBERT G · CIK 0001665364 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,450

F1 · date: The shares subject to the Award will vest on the date immediately preceding the first Annual Meeting following the Date of Grant, subject to the Eligible Director's continued Board service through such date.

F2 · kind: Automatic award under the Synopsys 2017 Non-Employee Directors Equity Incentive Plan.

Read SEC document
April 10, 2024 Filed Apr 12, 2024 16:48 UTC GrantCommon Stock 356 $0.00 $0.00
Disclosure

SEC source: 0001517737-24-000056 · edgardoc.xml · nonDerivative · entry 1

JOHNSON MERCEDES · CIK 0001225110 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,053

F1 · date: The shares subject to the Award will vest on the date immediately preceding the first Annual Meeting following the Date of Grant, subject to the Eligible Director's continued Board service through such date.

F2 · kind: Automatic award under the Synopsys 2017 Non-Employee Directors Equity Incentive Plan.

Read SEC document
April 10, 2024 Filed Apr 12, 2024 16:47 UTC GrantCommon Stock 356 $0.00 $0.00
Disclosure

SEC source: 0001517737-24-000055 · edgardoc.xml · nonDerivative · entry 1

CHIZEN BRUCE R · CIK 0001032834 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,218

F1 · date: The shares subject to the Award will vest on the date immediately preceding the first Annual Meeting following the Date of Grant, subject to the Eligible Director's continued Board service through such date.

F2 · kind: Automatic award under the Synopsys 2017 Non-Employee Directors Equity Incentive Plan.

Read SEC document
April 10, 2024 Filed Apr 12, 2024 16:46 UTC GrantCommon Stock 356 $0.00 $0.00
Disclosure

SEC source: 0001517737-24-000054 · edgardoc.xml · nonDerivative · entry 1

CHAFFIN JANICE · CIK 0001202443 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,678

F1 · date: The shares subject to the Award will vest on the date immediately preceding the first Annual Meeting following the Date of Grant, subject to the Eligible Director's continued Board service through such date.

F2 · kind: Automatic award under the Synopsys 2017 Non-Employee Directors Equity Incentive Plan.

Read SEC document
April 10, 2024 Filed Apr 12, 2024 16:44 UTC GrantCommon Stock 356 $0.00 $0.00
Disclosure

SEC source: 0001517737-24-000052 · edgardoc.xml · nonDerivative · entry 1

CASPER MARC N · CIK 0001216055 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,092

F1 · date: The shares subject to the Award will vest on the date immediately preceding the first Annual Meeting following the Date of Grant, subject to the Eligible Director's continued Board service through such date.

F2 · kind: Automatic award under the Synopsys 2017 Non-Employee Directors Equity Incentive Plan.

Read SEC document
April 03, 2024 Filed Apr 5, 2024 15:15 UTC
RUNKEL JOHN F JRGC & Corporate Secretary
SaleCommon Stock 5,319 $579.37 $3,081,662.65
Disclosure

SEC source: 0001517737-24-000040 · edgardoc.xml · nonDerivative · entry 1

RUNKEL JOHN F JR · CIK 0001206990 · GC & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

F1 · price: Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $577.305 to $580.220. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.

Read SEC document
March 25, 2024 Filed Mar 27, 2024 15:12 UTC PurchaseCommon Stock 250 $586.40 $146,601.10
Disclosure

SEC source: 0001517737-24-000038 · edgardoc.xml · nonDerivative · entry 2

CASPER MARC N · CIK 0001216055 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,736

Read SEC document
March 25, 2024 Filed Mar 27, 2024 15:12 UTC PurchaseCommon Stock 500 $584.97 $292,485.80
Disclosure

SEC source: 0001517737-24-000038 · edgardoc.xml · nonDerivative · entry 1

CASPER MARC N · CIK 0001216055 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,486

Read SEC document
March 15, 2024 Filed Mar 19, 2024 16:36 UTC
DE GEUS AARTDirector · EXECUTIVE CHAIR
Disposition to issuerRestricted Stock Units · Derivative 1,764 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001517737-24-000036 · edgardoc.xml · derivative · entry 6

DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,290

Underlying: Common Stock · 1,764 shares

Expires 2027-03-15

F2 · derivative.exercise_date: 25% of the units vest on the date shown followed by three equal annual installments, subject to continued service through each vesting date.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 16:36 UTC
DE GEUS AARTDirector · EXECUTIVE CHAIR
Tax withholdingCommon Stock 610 $550.03 $335,518.30
Disclosure

SEC source: 0001517737-24-000036 · edgardoc.xml · nonDerivative · entry 2

DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,983

F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the reporting person in connection with the vesting of an installment of the restricted stock unit award. The Compensation Committee approved the disposition of shares by the reporting person and the amount retained by the Company was not in excess of the amount of the tax liability.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 16:36 UTC
DE GEUS AARTDirector · EXECUTIVE CHAIR
Exercise / conversionCommon Stock 1,764 $0.00 $0.00
Disclosure

SEC source: 0001517737-24-000036 · edgardoc.xml · nonDerivative · entry 1

DE GEUS AART · CIK 0001249802 · Director · EXECUTIVE CHAIR

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,593

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.